From: Utilizing bioprinting to engineer spatially organized tissues from the bottom-up
Fabrication method | Building blocks | References | Advantages | Disadvantages |
---|---|---|---|---|
3D cell culture | Organ buds from endothelial cells and MSCs cultured with tissue-specific progenitors or relevant tissue samples | [28] | Generative potential Promote vascularization | Limited productivity Strict culture condition |
Mouse or human ISC-derived organoids in PEG hydrogels | [29] | Â | Â | |
Printed hMSCs cultured in alginate microgel | [30] | Â | Â | |
HiPSCs aggregates suspended in ECM solution to form embryoid bodies | [31] | Â | Â | |
Emulsification | Hollow spherical cell aggregates in gelatin microbeads generated by emulsification in oil bath | [32] | Easy to operate Moderate condition | Little control over size |
Microtissues of MSCs in chitosan-collagen matrix suspended in oil | [33] | Â | Â | |
Microfluidics | PEGDA microgel containing single MSC or chondrocyte produced by emulsification in microfluidic device | [34] | Consistency Control the size of droplets | Low throughput Require rapid crosslinking materials |
Alginate microgel containing single MSC or pre-adipocyte cell | [35] | Â | Â | |
GelMA microparticles containing fibroblasts produced by emulsification in microfluidic device | [36] | Â | Â | |
Cell electrospinning | Fibers of Matrigel containing mouse neuroblastoma cell produced by electrospinning | [37] | Guide cell aligned Efficient and fast nutrient exchange | Inhomogeneous cell density Low mechanical strength |
Fibers of alginate containing myoblast cells produced by cell electrospinning | [21] | Â | Â | |
Micromolding | ECM with micro vasculature structure molded by PDMS chips | [38] | Fabricate complex structure High precision | Require precise template Laborious |
Vasculature network on 3D PDMS chips | [39] | Â | Â | |
PLGA 3D microparticles assembled in a layer-by-layer sinister process | [40] | Â | Â | |
Bioprinting | Nanofibers of peptide amphiphiles containing fibroblasts and ADCSs | [41] | Automated Controllability High fidelity | Damage to cells Require printable biomaterials |
Vascular conduits of gelatin and alginate produced by microfluidic bioprinting | [42] | Â | Â | |
GelMA embedded with designed vascular network of HUVECs and fibroblasts | [24] | Â | Â | |
GelMA microgels with customized size and shape | [43] | Â | Â | |
Liver models of GelMA containing hepatocytes and human stellate cells with micro channels | [44] | Â | Â |